|
Volumn 300, Issue 5623, 2003, Pages 1212-1213
|
AIDS research: Drug trials without the drugs?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
HUMAN IMMUNODEFICIENCY VIRUS;
MEDICINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL RESEARCH;
COST CONTROL;
DRUG COST;
DRUG SCREENING;
FINANCIAL MANAGEMENT;
HEALTH CARE ORGANIZATION;
HEALTH CARE POLICY;
HEALTH PROGRAM;
HUMAN;
MEDICAL RESEARCH;
MONEY;
NOTE;
PRIORITY JOURNAL;
ANTI-HIV AGENTS;
CLINICAL TRIALS;
DEVELOPING COUNTRIES;
DRUG ADMINISTRATION SCHEDULE;
DRUG COSTS;
DRUG INDUSTRY;
FINANCING, GOVERNMENT;
HIV INFECTIONS;
HUMANS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
RESEARCH SUPPORT;
UNITED STATES;
HUMAN IMMUNODEFICIENCY VIRUS;
|
EID: 0038136920
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.300.5623.1212 Document Type: Note |
Times cited : (3)
|
References (0)
|